These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 27058624)

  • 1. Gene silencing of indoleamine 2,3-dioxygenase 2 in melanoma cells induces apoptosis through the suppression of NAD+ and inhibits in vivo tumor growth.
    Liu Y; Zhang Y; Zheng X; Zhang X; Wang H; Li Q; Yuan K; Zhou N; Yu Y; Song N; Fu J; Min W
    Oncotarget; 2016 May; 7(22):32329-40. PubMed ID: 27058624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Knockdown of indoleamine 2, 3-dioxygenase 2 (IDO2)gene inhibits tumor growth and enhances immune function in mice bearing melanoma].
    Liu Y; Liu H; Xiang Y; Chen X; Xu P; Min W
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Dec; 33(12):1605-1609. PubMed ID: 29382418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted siRNA silencing of indoleamine 2, 3-dioxygenase in antigen-presenting cells using mannose-conjugated liposomes: a novel strategy for treatment of melanoma.
    Chen D; Koropatnick J; Jiang N; Zheng X; Zhang X; Wang H; Yuan K; Siu KS; Shunnar A; Way C; Min WP
    J Immunother; 2014; 37(2):123-34. PubMed ID: 24509175
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Yang D; Zhang S; Fang X; Guo L; Hu N; Guo Z; Li X; Yang S; He JC; Kuang C; Yang Q
    J Med Chem; 2019 Oct; 62(20):9161-9174. PubMed ID: 31580660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene silencing of indoleamine 2,3-dioxygenase hinders tumor growth through angiogenesis inhibition.
    Pan J; Yuan K; Peng S; Huang Y; Zhang Y; Hu Y; Feng Y; Shi Y; Liu Y; Wang H; Zhou N; Min W
    Int J Oncol; 2017 Jun; 50(6):2136-2144. PubMed ID: 28498425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNAi-mediated human Nestin silence inhibits proliferation and migration of malignant melanoma cells by G
    Yang XH; Xia T; Zhang J; Yang SF; Tang HX; Tang T; Huang ZC; Zhong YS; He F; Xiang AP
    J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):895-903. PubMed ID: 29270750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel cancer therapy by skin delivery of indoleamine 2,3-dioxygenase siRNA.
    Yen MC; Lin CC; Chen YL; Huang SS; Yang HJ; Chang CP; Lei HY; Lai MD
    Clin Cancer Res; 2009 Jan; 15(2):641-9. PubMed ID: 19147770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IDO1 and IDO2 are expressed in human tumors: levo- but not dextro-1-methyl tryptophan inhibits tryptophan catabolism.
    Löb S; Königsrainer A; Zieker D; Brücher BL; Rammensee HG; Opelz G; Terness P
    Cancer Immunol Immunother; 2009 Jan; 58(1):153-7. PubMed ID: 18418598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silencing IDO2 in dendritic cells: A novel strategy to strengthen cancer immunotherapy in a murine lung cancer model.
    Liu Y; Xu P; Liu H; Fang C; Guo H; Chen X; Tan M; Zhang Y; Min W
    Int J Oncol; 2020 Aug; 57(2):587-597. PubMed ID: 32468023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of acetaminophen in skin B16-F0 melanoma tumor-bearing C57BL/6 mice.
    Vad NM; Kudugunti SK; Graber D; Bailey N; Srivenugopal K; Moridani MY
    Int J Oncol; 2009 Jul; 35(1):193-204. PubMed ID: 19513568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic antitumor effect with indoleamine 2,3-dioxygenase inhibition and temozolomide in a murine glioma model.
    Hanihara M; Kawataki T; Oh-Oka K; Mitsuka K; Nakao A; Kinouchi H
    J Neurosurg; 2016 Jun; 124(6):1594-601. PubMed ID: 26636389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-Targeted Gene Silencing IDO Synergizes PTT-Induced Apoptosis and Enhances Anti-tumor Immunity.
    Zhang Y; Feng Y; Huang Y; Wang Y; Qiu L; Liu Y; Peng S; Li R; Kuang N; Shi Q; Shi Y; Chen Y; Joshi R; Wang Z; Yuan K; Min W
    Front Immunol; 2020; 11():968. PubMed ID: 32582152
    [No Abstract]   [Full Text] [Related]  

  • 13. IDO2 is critical for IDO1-mediated T-cell regulation and exerts a non-redundant function in inflammation.
    Metz R; Smith C; DuHadaway JB; Chandler P; Baban B; Merlo LM; Pigott E; Keough MP; Rust S; Mellor AL; Mandik-Nayak L; Muller AJ; Prendergast GC
    Int Immunol; 2014 Jul; 26(7):357-67. PubMed ID: 24402311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination Cancer Immunotherapy with Dendritic Cell Vaccine and Nanoparticles Loaded with Interleukin-15 and Anti-beta-catenin siRNA Significantly Inhibits Cancer Growth and Induces Anti-Tumor Immune Response.
    Kheshti AMS; Hajizadeh F; Barshidi A; Rashidi B; Ebrahimi F; Bahmanpour S; Karpisheh V; Noukabadi FK; Kiani FK; Hassannia H; Atyabi F; Kiaie SH; Kashanchi F; Navashenaq JG; Mohammadi H; Bagherifar R; Jafari R; Zolbanin NM; Jadidi-Niaragh F
    Pharm Res; 2022 Feb; 39(2):353-367. PubMed ID: 35166995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing of PINK1 represses cell growth, migration and induces apoptosis of lung cancer cells.
    Liu L; Zuo Z; Lu S; Wang L; Liu A; Liu X
    Biomed Pharmacother; 2018 Oct; 106():333-341. PubMed ID: 29966978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IDO2-siRNA Carried by
    Zhao T; Guo M; Chen H; Zhou L; Guo J; Liu S; Wang Z; Huang W; Zhang Q; Zhong J; Wang M; Jia H; Zhang Y
    Curr Mol Pharmacol; 2023; 16(8):881-893. PubMed ID: 36999419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indoleamine 2,3-dioxygenase 2 depletion suppresses tumor growth in a mouse model of Lewis lung carcinoma.
    Yamasuge W; Yamamoto Y; Fujigaki H; Hoshi M; Nakamoto K; Kunisawa K; Mouri A; Nabeshima T; Saito K
    Cancer Sci; 2019 Oct; 110(10):3061-3067. PubMed ID: 31444833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The emerging roles of IDO2 in cancer and its potential as a therapeutic target.
    Li P; Xu W; Liu F; Zhu H; Zhang L; Ding Z; Liang H; Song J
    Biomed Pharmacother; 2021 May; 137():111295. PubMed ID: 33550042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetracycline-inducible shRNA targeting antisense long non-coding RNA HIF1A-AS2 represses the malignant phenotypes of bladder cancer.
    Chen M; Zhuang C; Liu Y; Li J; Dai F; Xia M; Zhan Y; Lin J; Chen Z; He A; Xu W; Zhao G; Guo Y; Cai Z; Huang W
    Cancer Lett; 2016 Jun; 376(1):155-64. PubMed ID: 27018306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNAi-mediated MMP-9 silencing inhibits mouse melanoma cell invasion and migration in vitro and in vivo.
    Tang ZY; Liu Y; Liu LX; Ding XY; Zhang H; Fang LQ
    Cell Biol Int; 2013 Aug; 37(8):849-54. PubMed ID: 23554050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.